Änderungen von Dokument Pustulosis subcornealis Sneddon-Wilkinson
Zuletzt geändert von Thomas Brinkmeier am 2025/04/25 20:40
<
>
bearbeitet von Thomas Brinkmeier
am 2019/02/02 21:13
am 2019/02/02 21:13
bearbeitet von Thomas Brinkmeier
am 2021/06/02 22:04
am 2021/06/02 22:04
Änderungskommentar:
Es gibt keinen Kommentar für diese Version
Zusammenfassung
Details
- Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf
-
- Author
-
... ... @@ -1,0 +1,1 @@ 1 +XWiki.Dermatologie_Kompendium - Größe
-
... ... @@ -1,0 +1,1 @@ 1 +620.9 KB - Inhalt
- Wikiderm.EntryClass[0]
-
- Eintrag
-
... ... @@ -65,9 +65,45 @@ 65 65 (% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV 66 66 67 67 (% class="Eintrag-2" %) 68 -(% class="Feature" %)DD:(%%) (% class="Abbreviation" %)AGEP(%%) , Dermatitis herpetiformis, eosinophile pustulöse Follikulitis Ofuji, Impetigo contagiosa, Pemphigus foliaceus, Psoriasis pustulosa68 +(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%) 69 69 70 +(% class="Ebene-1" %) 71 +(% class="Bullet" %)-(%%) Dermatitis herpetiformis 72 + 73 +(% class="Ebene-1" %) 74 +(% class="Bullet" %)-(%%) eosinophile pustulöse Follikulitis Ofuji 75 + 76 +(% class="Ebene-1" %) 77 +(% class="Bullet" %)-(%%) Impetigo contagiosa 78 + 79 +(% class="Ebene-1" %) 80 +(% class="Bullet" %)-(%%) Pemphigus foliaceus 81 + 70 70 (% class="Eintrag-2" %) 83 + 84 + 85 +(% class="Ebene-1" %) 86 +(% class="Bullet" %)-(%%) Psoriasis pustulosa 87 + 88 +(% class="Ebene-1" %) 89 +(% class="Bullet" %)-(%%) Tinea incognito 90 + 91 +(% class="Ebene-2" %) 92 +(% class="Feature" %)Lit:(%%) [[Kalkan, G., Demirseren, D. D, Güney, C. A, & Aktaş, A. (2020). A case of tinea incognito mimicking subcorneal pustular dermatosis. Dermatology Online Journal, 26(2)>>url:https://escholarship.org/uc/item/46g9x55w]] 93 + 94 +(% class="Eintrag-2" %) 95 +(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}} 96 + 97 +(% class="Ebene-1" %) 98 +(% class="Bullet" %)-(%%) Open Access Maced J Med Sci. 2020 Jun 05; 8(T1):12-15. [[https:~~/~~/doi.org/10.3889/oamjms.2020.4870>>url:https://doi.org/10.3889/oamjms.2020.4870]] 99 + 100 +(% class="Ebene-1" %) 101 +(% class="Bullet" %)-(%%) International Journal of Women's Dermatology, Volume 6, Issue 3, 2020, Pages 131-136, ISSN 2352-6475, [[https:~~/~~/doi.org/10.1016/j.ijwd.2020.02.003>>url:https://doi.org/10.1016/j.ijwd.2020.02.003]] 102 + 103 +(% class="Ebene-1" %) 104 +(% class="Bullet" %)-(%%) SAGE Open Med Case Rep. 2019 Jan 30;7:2050313X19826432. [[http:~~/~~/doi.org/10.1177/2050313X19826432>>url:http://doi.org/10.1177/2050313X19826432]] 105 + 106 +(% class="Eintrag-2" %) 71 71 (% class="Feature" %)Th:(%%) (% class="Bullet" %)-(%%) lokal 72 72 73 73 (% class="Ebene-2" %) ... ... @@ -91,6 +91,12 @@ 91 91 (% class="Ebene-5" %) 92 92 (% class="Feature" %)Lit:(%%) (% class="Abbreviation" %)CR(%%) 93 93 130 +(% class="Ebene-2" %) 131 +(% class="Bullet" %)-(%%) Dapson Gel 132 + 133 +(% class="Ebene-3" %) 134 +(% class="Feature" %)Lit:(%%) J Dermatol. 2019 Jun 24. [[http:~~/~~/doi.org/10.1111/1346-8138.14953>>url:http://doi.org/10.1111/1346-8138.14953]] 135 + 94 94 (% class="Ebene-1" %) 95 95 (% class="Bullet" %)-(%%) systemisch 96 96 ... ... @@ -134,6 +134,12 @@ 134 134 (% class="Feature" %)Lit:(%%) Dermatol Ther. 2019 Jan 14:e12818. [[http:~~/~~/doi.org/10.1111/dth.12818>>url:http://doi.org/10.1111/dth.12818]] 135 135 136 136 (% class="Ebene-2" %) 179 +(% class="Bullet" %)-(%%) Apremilast 180 + 181 +(% class="Ebene-3" %) 182 +(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]] 183 + 184 +(% class="Ebene-2" %) 137 137 (% class="Bullet" %)-(%%) Anti-TNF-alpha 138 138 139 139 (% class="Ebene-3" %) ... ... @@ -155,4 +155,10 @@ 155 155 (% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich) 156 156 157 157 (% class="Ebene-5" %) 158 -(% class="Feature" %)PT:(%%) CR 206 +(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%) 207 + 208 +(% class="Ebene-2" %) 209 +(% class="Bullet" %)-(%%) Guselkumab 210 + 211 +(% class="Ebene-3" %) 212 +(% class="Feature" %)Lit:(%%) Int J Dermatol. 2021 Apr;60(4):e153-e154. [[http:~~/~~/doi.org/10.1111/ijd.15311>>url:http://doi.org/10.1111/ijd.15311]]